Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Detox Withdrawal Management topic

No spam. Unsubscribe anytime.

Pioneer Human Services detox staff describe increasing admissions, fentanyl‑era treatment challenges

3090698 · April 23, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Pioneer Human Services reported to the Whatcom County task force that detox admissions and clinical demand are fluctuating, fentanyl and benzodiazepine contamination complicate withdrawal management, and a new peer bridger program and supported‑housing linkages are under way.

Pioneer Human Services’ withdrawal‑management program told the Whatcom County Incarceration Prevention Reduction Task Force on April 21 that admissions and clinical needs are rising and changing, driven in part by fentanyl and by increases in illicit benzodiazepine exposure.

Rob Sullivan, regional director of residential services at Pioneer Human Services, described the facility as a voluntary residential program for adults seeking acute withdrawal management and said the average length of stay is three to five days. “We provide a clean and safe environment for recovery from intoxication and withdrawal,” Sullivan said.

Sullivan and Pioneer staff said the program’s admission criteria exclude people needing advanced medical monitoring (for example, oxygen), pregnant people beyond 24 weeks, and people with needs for one‑to‑one nursing care. In recent months staff said benzodiazepine exposure—often illicit and mixed into other street drugs—has increased and that benzodiazepine withdrawal can be dangerous and often requires hospital‑level care.

“How we treat withdrawal has changed since fentanyl,” Sullivan said. He described “macrodosing” approaches for Suboxone (buprenorphine) in some clients who now present earlier and more severely in withdrawal than with historic opioid use, while noting ongoing clinical uncertainty and the need for protocol adjustments that Pioneer is coordinating with public‑health clinicians.

Service volume and outcomes: Pioneer reported a year of variable utilization. Sullivan gave figures for 2024 and early 2025 and later clarified counts in response to questions: he said the program recorded roughly 1,104 admissions in the year under discussion, of which about 795 were unduplicated individuals and about 309 were repeat admissions. Sullivan said about 774 to 805 people completed withdrawal management services in 2024 depending on the counting method used.

Program changes and partnerships: Pioneer implemented trauma‑informed care training starting in 2024, embedded supported‑housing connections and launched a peer‑bridger program in April 2025 to improve post‑discharge engagement. Sullivan said Pioneer refers people to and accepts referrals from PeaceHealth and from mobile medical units that can provide medication‑assisted treatment such as methadone and buprenorphine.

Barriers: Sullivan and task force members discussed difficulty finding medical detox beds for people with complicated withdrawals, and that local hospital programs and other detox providers are often full. Sullivan said Evergreen Recovery and hospital programs are used when appropriate but have admission constraints.

Ending: The task force asked Pioneer to share clearer, tabulated admission and unduplicated counts. Sullivan said Pioneer will work to reduce intake roadblocks and continue to adapt clinical protocols in response to fentanyl and benzodiazepine‑related changes.